Assignee
SpecGx LLC
US·15 granted patents·8 pending applications·5 citations·filing 2015–2025
Top patents by PatentIndex Score
23 records- 0183US2025368630A1Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2025·Application pending·0 cites
- 0281US12371423B2Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2022·Granted Jul 29, 2025·0 cites·21 claims
- 0378US11077024B2Systems and methods for high humidity curing within tablet coating systemSpecGx LLC·Filed 2019·Granted Aug 3, 2021·2 cites·17 claims
- 0477US10927068B2Process for preparing acylated amphetamine derivativesSpecGx LLC·Filed 2018·Granted Feb 23, 2021·1 cites·17 claims
- 0576US2022079938A1Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compoundsSpecGx LLC·Filed 2021·Application pending·0 cites
- 0675US11033508B2Delayed sustained release pharmaceutical compositionsSpecGx LLC·Filed 2018·Granted Jun 15, 2021·2 cites·7 claims
- 0773US12208094B2Extended release, abuse deterrent dosage formsSpecGx LLC·Filed 2022·Granted Jan 28, 2025·0 cites·20 claims
- 0873US2019381033A1PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDSSpecGx LLC·Filed 2019·Application pending·0 cites
- 0972US2021061793A1Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2020·Application pending·0 cites
- 1071US11096887B2Extended release, abuse deterrent pharmaceutical compositionsSpecGx LLC·Filed 2019·Granted Aug 24, 2021·0 cites·15 claims
- 1170US2020338068A1PROCESSES FOR PREPARING MORPHINAN-6-ONE PRODUCTS WITH LOW LEVELS OF a,ß-UNSATURATED KETONE COMPOUNDSSpecGx LLC·Filed 2020·Application pending·0 cites
- 1267US11666509B2Systems and methods for high humidity curing within tablet coating systemSpecGx LLC·Filed 2021·Granted Jun 6, 2023·0 cites·14 claims
- 1365US10899749B2Preparation of sufentanil citrate and sufentanil baseSpecGx LLC·Filed 2019·Granted Jan 26, 2021·0 cites·10 claims
- 1464US11583493B2Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesSpecGx LLC·Filed 2020·Granted Feb 21, 2023·0 cites·16 claims
- 1564US11517521B2Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesSpecGx LLC·Filed 2018·Granted Dec 6, 2022·0 cites·8 claims
- 1663US11446293B2Extended release, abuse deterrent dosage formsSpecGx LLC·Filed 2020·Granted Sep 20, 2022·0 cites·20 claims
- 1762US2018280289A1Immediate release, abuse deterrent pharmaceutical compositionsSpecGx LLC·Filed 2018·Application pending·0 cites
- 1860US2019358164A1Zero-order modified release solid dosage formsSpecGx LLC·Filed 2019·Application pending·0 cites
- 1956US11617712B2Abuse deterrent immediate release formulations comprising non-cellulose polysaccharidesSpecGx LLC·Filed 2015·Granted Apr 4, 2023·0 cites·20 claims
- 2053US11065246B2Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent propertiesSpecGx LLC·Filed 2017·Granted Jul 20, 2021·0 cites·18 claims
- 2149US11478426B2Abuse deterrent immediate release capsule dosage formsSpecGx LLC·Filed 2019·Granted Oct 25, 2022·0 cites·16 claims
- 2242US2019183896A1One step milling process for preparing micronized paliperidone estersSpecGx LLC·Filed 2018·Application pending·0 cites
- 2338US11464741B2Spray dried compositions having different dissolution profiles and processes for their preparationSpecGx LLC·Filed 2015·Granted Oct 11, 2022·0 cites·1 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →